MKK7-JNK activator 1
MKK7-JNK activator 1 (Compound 10) is a MKK7-JNK pathway activator. MKK7-JNK activator 1 effectively inhibits the proliferation and migration of MDA-MB-468 cells, induces G2/M phase arrest and caspase -dependent apoptosis (independent of ROS production) . MKK7-JNK activator 1 significantly increases the levels of p-MKK7 and p-JNK, but does not affect p-ERK or p-p38. MKK7-JNK activator 1 can be used for the study of triple-negative breast cancer (TNBC) [1].
Product Specifications
CAS Number
3100092-62-1
UNSPSC
12352005
Target
Apoptosis; Caspase; JNK; p38 MAPK
Related Pathways
Apoptosis; MAPK/ERK Pathway
Field of Research
Cancer
Smiles
CC1=NC2=C(OCC3=CC=CC(I)=C3)C(Br)=CC(Br)=C2C=C1
Molecular Formula
C17H12Br2INO
Molecular Weight
533.00
References & Citations
[1]Ma L, et al. Synthesis and evaluation of 8- (benzyloxy) -5,7-dibromo-2-methylquinoline derivatives as inducers of apoptosis in triple-negative breast cancer MDA-MB-468 cells via MKK7-JNK pathway activation. Bioorg Chem. 2025 Oct 17;166:109117.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Caspase 3; Caspase 8; Caspase 9
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PDEH100772-02 100 µg
Recombinant Human GLP-1 protein (His&SUMO tag)
Sign In for Pricing
View Details PDEH100772-03 500 µg
Recombinant Human GLP-1 protein (His&SUMO tag)
Sign In for Pricing
View Details 
BNC472224-100 1x 100 µL
S100A4 / Metastasin / Calvasculin (Marker of Tumor Metastasis) (CPTC-S100A4-3), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details